Five Day Filter

Like Comment

This week’s Filter finds Merck jumping (late) into the VC and Twitterspheres and a round-up of agbiotech news from the Southern hemisphere. As always, we welcome your comments and questions.

Michael Francisco

Go to the profile of Michael Francisco

Michael Francisco

Senior Editor, Nature Biotechnology

No comments yet.